Mineralys Therapeutics, Inc. MLYS

Full chart Compare
Set alert

Price alert · MLYS

All alert types
15.46 USD -1.54 (-9.06%)

Nov 5, 2026, 3:40 PM EST

15.37 Day range 17.66
15.33 52-week range 47.65
YTD
-57.40%
1 year
-61.01%

Ownership

Held by insiders 0.73%
Held by institutions 116.44%
Float held by institutions 117.29%
Institutions 324

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Catalys Pacific, LLC8.82%7,799,518132.59MSep 29, 2026
RA Capital Management, L.P.8.70%7,692,750130.78MJun 29, 2026
Blackrock Inc.6.66%5,887,038100.08MJun 29, 2026
Samsara BioCapital, LLC6.64%5,871,01899.81MJun 29, 2026
FMR, LLC5.10%4,511,68976.70MJun 29, 2026
State Street Corporation4.68%4,141,63670.41MJun 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
SmallCap World Fund Inc2.83%2,502,85442.55MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.23%1,968,12433.46MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.79%1,584,49326.94MSep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.66%1,468,68924.97MSep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio1.33%1,180,00020.06MAug 30, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund1.09%962,99916.37MSep 29, 2026
MLYS insiders
InsiderRelationLatest transactionDateShares held
AKKARAJU SRINIVASDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Feb 18, 20265,877,220
CONGLETON JONChief Executive OfficerSaleJul 12, 2026603,621
FERGUSON JAMES J. IIIOfficerStock Award(Grant)Aug 9, 2026102,400
KARYDAS DAPHNEDirectorSaleSep 14, 20266,200
LEVY ADAM SCOTTChief Financial OfficerStock Award(Grant)Feb 18, 202648,538
RA CAPITAL MANAGEMENT, L.P.Beneficial Owner of more than 10% of a Class of SecurityPurchaseMar 29, 20260